Fostamatinib
Pro00113327
Phase 1 small_molecule active
Quick answer
Fostamatinib for Chronic Graft Versus Host Disease is a Phase 1 program (small_molecule) at RIGEL PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RIGEL PHARMACEUTICALS INC
- Indication
- Chronic Graft Versus Host Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active